OMERS ADMINISTRATION Corp Increases Stock Holdings in GE HealthCare Technologies Inc. $GEHC

OMERS ADMINISTRATION Corp lifted its stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 53.1% in the first quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 22,832 shares of the company’s stock after purchasing an additional 7,922 shares during the quarter. OMERS ADMINISTRATION Corp’s holdings in GE HealthCare Technologies were worth $1,625,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently bought and sold shares of the stock. Laurel Wealth Advisors LLC bought a new stake in GE HealthCare Technologies in the fourth quarter worth $26,000. Optima Capital LLC bought a new position in GE HealthCare Technologies during the fourth quarter valued at $27,000. Godfrey Financial Associates Inc. purchased a new stake in shares of GE HealthCare Technologies in the fourth quarter valued at $27,000. Montag A & Associates Inc. raised its stake in shares of GE HealthCare Technologies by 105.4% in the fourth quarter. Montag A & Associates Inc. now owns 341 shares of the company’s stock valued at $28,000 after acquiring an additional 175 shares during the period. Finally, Transamerica Financial Advisors LLC lifted its holdings in shares of GE HealthCare Technologies by 331.6% in the 4th quarter. Transamerica Financial Advisors LLC now owns 341 shares of the company’s stock worth $28,000 after acquiring an additional 262 shares during the last quarter. Hedge funds and other institutional investors own 82.06% of the company’s stock.

GE HealthCare Technologies Trading Up 12.2%

Shares of GEHC opened at $71.90 on Thursday. The firm has a market capitalization of $32.71 billion, a price-to-earnings ratio of 17.20, a PEG ratio of 1.74 and a beta of 0.72. The company has a debt-to-equity ratio of 0.95, a current ratio of 1.22 and a quick ratio of 0.95. GE HealthCare Technologies Inc. has a 1-year low of $58.75 and a 1-year high of $89.77. The company has a 50-day moving average of $63.83 and a 200 day moving average of $70.69.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its earnings results on Wednesday, July 29th. The company reported $1.13 EPS for the quarter, topping analysts’ consensus estimates of $1.04 by $0.09. GE HealthCare Technologies had a net margin of 9.10% and a return on equity of 20.46%. The business had revenue of $5.29 billion for the quarter, compared to the consensus estimate of $5.26 billion. During the same period in the prior year, the firm earned $1.06 EPS. The company’s revenue for the quarter was up 5.8% compared to the same quarter last year. On average, research analysts expect that GE HealthCare Technologies Inc. will post 4.89 EPS for the current year.

GE HealthCare Technologies Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, August 14th. Shareholders of record on Friday, July 24th will be issued a dividend of $0.035 per share. This represents a $0.14 annualized dividend and a yield of 0.2%. The ex-dividend date is Friday, July 24th. GE HealthCare Technologies’s dividend payout ratio (DPR) is presently 3.35%.

Wall Street Analysts Forecast Growth

A number of research firms recently commented on GEHC. Hovde Group began coverage on shares of GE HealthCare Technologies in a research note on Friday, July 17th. They set a “market perform” rating and a $14.00 price target for the company. Piper Sandler reissued a “buy” rating on shares of GE HealthCare Technologies in a research note on Wednesday. HSBC dropped their target price on GE HealthCare Technologies from $100.00 to $90.00 in a research report on Thursday, April 30th. Argus cut their target price on GE HealthCare Technologies from $95.00 to $80.00 and set a “buy” rating on the stock in a research note on Tuesday, May 19th. Finally, Jefferies Financial Group reduced their price target on GE HealthCare Technologies from $105.00 to $90.00 in a report on Thursday, April 30th. Ten equities research analysts have rated the stock with a Buy rating, ten have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average price target of $76.59.

Key GE HealthCare Technologies News

Here are the key news stories impacting GE HealthCare Technologies this week:

• Positive Sentiment: GE HealthCare reported adjusted earnings of $1.13 per share, exceeding the $1.04 analyst consensus, while revenue reached approximately $5.29 billion versus expectations of $5.26 billion. Revenue rose about 5.8% year over year, helped by increased orders and healthy demand. GE HealthCare beats quarterly profit estimates on strong imaging demand, tariff refunds
• Positive Sentiment: Orders grew approximately 11% organically, book-to-bill reached a post-spin-off record near 1.15, and backlog climbed to a record $23.9 billion. The metrics provide stronger future revenue visibility and suggest hospitals are resuming capital investments in imaging and diagnostic infrastructure. GEHC Q2 Earnings and Revenues Beat Estimates
• Positive Sentiment: Pharmaceutical Diagnostics delivered particularly strong growth, while imaging demand remained healthy. Management also said it is reviewing strategic alternatives for the underperforming Patient Care Solutions business, potentially allowing GE HealthCare to improve margins by restructuring or divesting the unit. GE HealthCare reports second quarter 2026 financial results
• Positive Sentiment: BTIG Research raised its GEHC price target from $75 to $79 and assigned a “Buy” rating, reinforcing the positive earnings reaction and suggesting additional upside based on the firm’s estimates. BTIG raises GE HealthCare price target
• Neutral Sentiment: Unusually high call-option activity showed traders purchasing roughly 8,956 contracts, about 45% above average. This reflects bullish speculative interest but does not directly change GE HealthCare’s fundamentals.
• Negative Sentiment: The earnings beat benefited from a tariff refund and a lower tax rate, which may not recur. Adjusted EBIT margins also contracted by roughly 40 basis points to about 14.2%, with Patient Care Solutions reporting a sharp organic revenue decline and negative EBIT.

Insider Transactions at GE HealthCare Technologies

In other news, Director Watkin Phoebe L. Yang purchased 1,000 shares of the company’s stock in a transaction dated Friday, May 8th. The shares were acquired at an average price of $63.01 per share, with a total value of $63,010.00. Following the transaction, the director owned 13,702 shares of the company’s stock, valued at $863,363.02. This represents a 7.87% increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Rodney F. Hochman purchased 1,618 shares of the business’s stock in a transaction dated Tuesday, May 12th. The shares were purchased at an average price of $62.03 per share, for a total transaction of $100,364.54. Following the purchase, the director owned 1,618 shares of the company’s stock, valued at approximately $100,364.54. This trade represents a ∞ increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. In the last quarter, insiders acquired 15,928 shares of company stock valued at $1,005,761. Company insiders own 0.36% of the company’s stock.

About GE HealthCare Technologies

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.